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Abstract
Background: Data regarding associations among physical activity (PA) level, body composition, and prevalence of
cardiovascular diseases in Asian populations are rare.
Methods: The International Physical Activity Questionnaire (IPAQ) was utilized to estimate PA levels and analyze the
association of PA level with various body composition parameters and the prevalence of cardiovascular diseases by
using data from the Korean National Health and Nutrition Examination Survey from 2008 to 2011.
Results: Moderate and high PA levels were associated with lower prevalence of hypertension and diabetes mellitus,
and lower concentrations of serum ferritin, parathyroid hormone, and alkaline phosphatase. Sarcopenia (low vs. moderate
vs. high PA group: 14.3% vs. 10.5% vs. 7.3%, p = 0.001), underweight (5.7% vs. 4.9% vs. 3.5%, p= 0.001), and central obesity
(7.8% vs. 6.9% vs. 6.3%, p = 0.002) were more often observed in the low PA group. The prevalence rates of cardiovascular
diseases were lower in the moderate (odds ratio [OR], 0.822; 95% confidence interval [CI], 0.737–0.916; p = 0.001) and high
activity groups (OR, 0.663; 95% CI, 0.589–0.748; p= 0.001) than in the low activity group, even after adjusting for age, sex,
smoking, underlying disease, and general or abdominal obesity and muscle mass.
Conclusion: Regular physical activity was associated with a low prevalence of cardiovascular diseases (stroke, myocardial
infarction, stable angina, and chronic renal disease), which was independent of body composition and conventional risk
factors in the Korean population, with a positive dose-response relationship.
Keywords: Cardiovascular disease, Obesity, Sarcopenia, Physical activity
* Correspondence: RJH54112@yuhs.ac
2Division of Cardiology, Department of Internal Medicine, Yongin Severance
Hospital, Yonsei University College of Medicine, Yongin, Republic of Korea
3Division of Cardiology, Yongin Severance Hospital, Yonsei University College
of Medicine, 225 Geumhak-ro, Cheoin-gu, Yongin 17046, South Korea
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Kim et al. BMC Public Health  (2017) 17:275 
DOI 10.1186/s12889-017-4126-x
Background
Cardiovascular disease (CVD) is the leading cause of
death and disability worldwide. According to World
Health Organization global estimates of mortality and
burden of disease, 30% of all global deaths were associ-
ated with CVD [1, 2]. Besides increasing mortality, CVD
leads to substantial health-care expenditures and decline
in economic growth due to decreased work activity and
permanent disability [3]. CVD is a multifactorial disease
process influenced by various biological and behavioral
characteristics. Smoking cessation, physical activity (PA),
weight reduction, and healthy diet are the major compo-
nents of an effective CVD prevention program [4].
These lifestyle modifications are a proven cost-effective
strategy for both primary and secondary prevention of
CVD [5–8].
Regular PA clearly decreases the risk of CVD at the
same magnitude as that of smoking cessation [9–11].
Previous reports documented that the median risk reduc-
tion for CVD was about 40% when comparing between
most and least active subjects. These results persisted even
after adjusting for traditional cardiovascular risk factors
such as hypertension (HTN), dyslipidemia, and diabetes
mellitus (DM) [12, 13]. Based on this evidence, the
federal government issued its first-ever PA guidelines
for Americans in 2008 [14].
However, relatively few studies have examined the re-
lationship between PA level and coronary heart disease/
CVD risk in nonwhite populations [15]. Moreover, only
few studies have simultaneously demonstrated the asso-
ciation among PA level; clinical measures of body com-
position such as waist circumference (WC), muscle
mass, or body mass index (BMI); and the prevalence of
CVD.
Therefore, this study was conducted to assess the re-
lationship of PA level as defined by the International
Physical Activity Questionnaire-short form (IPAQ-SF)
[16] with body composition and prevalence of CVD by
analyzing data from the fifth Korean National Health
and Nutrition Examination Survey (KNHANES) con-
ducted from 2008 to 2011.
Methods
Study population
In this study, data collected from 2008 to 2011 through
the KNHANES were used. The target population of the
KNHANES included all non-institutionalized Korean
civilians of at least 1 year of age. A stratified multi-stage
probability sampling design was used. The subjects were
selected from sampling units predicated on geographical
area, sex, and age, determined by using household
registries. Each population group was assigned a
weighted value based on geographical and demographic
characteristics to allow estimates to be calculated for
the entirety of the Korean population. KNHANES is
composed of three components surveys: a health inter-
view, heath examination and nutrition survey. The
health interview and health examination are performed
by trained medical staff and interviewers at the mobile
examination center. One week after the health inter-
view and health examination surveys, dieticians visit
the home of participants for the nutrition survey. The
surveys collect detailed information on socioeconomic
status, health behaviours, quality of life, healthcare
utilization, anthropometric measures, biochemical pro-
files using fasting blood serum and urine, measures for
dental health, vision, hearing and bone density, X-ray
test results, food intake and dietary behavior. The over-
all response rate was 76.1% for the heath interview and
examination survey and 82.4% for the nutrition survey.
KNHANES data are valuable sources for monitoring
changes in risk factors and diseases and identifying tar-
get groups in need of interventions. Korea Centers for
Disease Control and Prevention (KCDC) and related
academic societies have managed external quality con-
trol programmes for all steps (including survey admin-
istration, data collection, laboratory analysis and data
processing) as well as internal quality assurance and
control procedures [17]. The questionnaires used in
this study included questions that addressed the demo-
graphic, socioeconomic, dietary, and medical history of
each respondent [18]. After excluding 9882 subjects
younger than 20 years of age and 1777 subjects without
information on PA, 26,294 subjects consisting of 11,213
male subjects (42.6%) and 15,081 female subjects
(57.4%) were included in our final analysis. The Korea
Centers for Disease Control and Prevention (KCDC)
Institutional Review Board approved the survey proto-
col, and all participants provided written informed con-
sent. However, this study did not require any ethics
approval, because the KNHANES data are publicly
available.
Definition of PA
The IPAQ-SF is used to estimate the overall PA level of
an individual in metabolic equivalent (MET)-min/week
by determining the duration (in minutes) and number of
days (in 1 week) of engagement in three specific types of
activity (walking, moderate-intensity activities, and high-
intensity activities) across a comprehensive set of do-
mains (leisure time, work-related and transport-related
physical activities, and domestic and gardening activities)
in the past 7 days. The IPAQ-SF has acceptable reliability
and validity [16, 19] in previous studies. Walking fast,
carrying light loads, bicycling at a regular pace, golf or ten-
nis are including in moderate intensity activities and heavy
lifting (more than 20 kg), digging, aerobics, basketball,
swimming or fast bicycling are including in high-intensity
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activities. MET is a unit that is used to estimate the
amount of oxygen used by the body during PA. MET-
min/week is computed by multiplying the MET score of
an activity (3.3 for walking, 4.0 for moderate-intensity
activities, and 8.0 for vigorous intensity activities) to the
minutes and days (or sessions) of engagement. Respon-
dents were classified according to three PA levels, namely
low, moderate, or high, according to the cutoff total MET-
min/week in each category [20] as follows:
Category 1 Low
Individuals who did not meet the criteria for Categories
2 (moderately active) and 3 (highly active) were
considered to have low PA levels or as physically
inactive.
Category 2 Moderate
a) Three or more days of vigorous-intensity activities
of at least 20 min/day;
b) Five or more days of moderate-intensity activities
and/or walking of at least 30 min/day; or
c) Five or more days of any combination of walking,
moderate-intensity activities, and vigorous-intensity
activities that could attain a minimum total PA of at
least 600 MET-min/week.
Category 3 High
a) Vigorous-intensity activities for at least 3 days that
could attain a minimum total PA of at least 1500
MET-min/week; or
b) Seven or more days of any combination of walking,
moderate-intensity activities, or vigorous-intensity
activities that could attain a minimum total PA of at
least 3000 MET-min/week.
Definition of sarcopenia, obesity, and metabolic
syndrome
Appendicular skeletal muscle mass (ASM) was measured
by using dual-energy X-ray absorptiometry (QDR 4500A;
Hologic Inc.). ASM (in kilograms) was defined as the sum
of the lean soft tissue masses of the arms and legs [21]. To
define sarcopenia, we assessed ASM as a percentage of
body weight (ASM/weight [Wt.]), which was modified
from the method used in the study by Janssen et al [22],
and defined as <2 SD below the sex-specific mean for a
young reference group from the data sets of the 2008 and
2011 KNHANES (960 male subjects and 1240 female sub-
jects, 20–30 years old). The cutoff point for sarcopenia
was 29.0% for male subjects and 22.9% for female
subjects.
The International Obesity Task Force (IOTF) and
World Health Organization (WHO) regional office for
the Western Pacific region recommend defining obesity
in Asians as a BMI of ≥25 kg/m2. Subsequently, the
Korean Society for the Study of Obesity (KSSO) adopted
this definition [23]. Thus, subjects were classified as
obese if their BMIs were ≥25 kg/m2 according to the
standards of the IOTF, WHO, and KSSO.
The modified National Cholesterol Education Program’s
Adult Treatment Panel III (NCEP ATP III) Asian criteria
for metabolic syndrome was used, requiring 3 or more of
the following criteria: WC, ≥90 cm for male subjects
and ≥85 cm for female subjects [24]; triglyceride level,
≥150 mg/dl; high-density lipoprotein (HDL)-cholesterol
level, ≤40 mg/dl for male subjects and ≤50 mg/dl for
female subjects; blood pressure, ≥130/85 mm Hg; and
fasting glucose level, ≥100 mg/dl.
Definition of CVD
CVD was defined as previous cardiovascular events such
as angina pectoris, myocardial infarction, and stroke
[25]. We also included chronic renal disease, which was
defined as chronic kidney disease stage ≥3 (glomerular
filtration rate [GFR] of ≥60 ml/min/1.73 m2) in CVD
[26, 27]. GFR was estimated by using the Modification
of Diet in Renal Disease (MDRD) equation.
Statistical analyses
All data were expressed as number and percentage (%)
or mean ± standard deviation. Continuous variables were
compared by using an independent t test or analysis of
variance. Categorical variables were compared by using
the chi-square test or Fisher exact test. The odds ratio
(OR) for stroke, myocardial infarction, angina pectoris,
and chronic renal disease according to physical groups
were calculated by using logistic regression. The
multivariable-adjusted model was adjusted for known
confounding factors such as age, sex, hypertension,
DM, and smoking. P values of <0.05 were considered
statistically significant. The Statistical Package for the
Social Sciences (SPSS, version 19; SPSS, Chicago, IL,
USA) was used for these analyses.
Results
Table 1 shows the baseline characteristics of the partici-
pants according to their activity levels. Low, moderate,
and high activity groups comprised 20.2, 45.6, and
34.2% of the study population, respectively. Older and
female subjects were more prevalent in the low activity
group. Resting heart rate was lower in the high activity
group than in low or moderate activity group. Serum
concentrations of fasting glucose (low > moderate =
high activity group, p = 0.001), alkaline phosphatase
(low >moderate = high activity group, p = 0.001), para-
thyroid hormone (low >moderate > high activity group,
p = 0.001), ferritin (low >moderate > high activity group,
p = 0.001) were highest, but vitamin D level was lowest
in the low activity group. The associations between
clinical measures of body composition and PA are sum-
marized in Table 2. ASM was higher in the high activity
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group (high > moderate = low activity group, p = 0.001).
Obesity measure according to BMI did not differ between
the groups, but sarcopenia had an inverse relationship
with PA level (OR in moderate activity = 0.744, OR in high
activity = 0.516, both compared with low activity group,
p = 0.001). Each metabolic syndrome component was
also associated with PA level, and the risk of metabolic
syndrome was higher in the low activity group.
The ORs for the prevalence of CVD, as calculated by
using logistic regression analyses, are shown in Table 3.
On the univariate analysis, the prevalence of CVD was sig-
nificantly lower in the moderate (OR = 0.722, p = 0.001) or
high activity group (OR = 0.610, p = 0.001) than in the low
activity group. This difference in prevalence remained sig-
nificant after adjustment for conventional risk factors of
CVD, including age, HTN, DM, smoking, and male sex.
Besides PA level, sarcopenia, BMI, and central obesity
were associated with the prevalence of CVD (Table 3).
Then, we performed a multivariate logistic analysis in
order to adjust for the body composition parameters and
metabolic risk components, which were regarded as
independent risk factors of CVD. In the comparison
between high or moderate activity group and the low ac-
tivity group, the odds ratio was still significant after ad-
justment for each variable, except for sarcopenia, which
showed a difference only between the high and low











Age (years) a53 ± 17 b49 ± 16 b49 ± 15 0.001
Male 1951 (36.7) 4651 (38.8) 4611 (51.3) 0.001
Hypertension 2099 (39.5) 4155 (34.6) 3142 (35.0) 0.001
Diabetes mellitus 669 (12.6) 1302 (10.9) 1074 (11.9) 0.002
Dyslipidemia 488 (9.2) 1168 (9.7) 821 (9.1) 0.283
Current smoker 1573 (29.6) 3471 (28.9) 3431 (38.1) 0.001
Systolic blood pressure (mm Hg) a120 ± 18 b118 ± 18 c119 ± 17 0.001
Diastolic blood pressure (mm Hg) a76 ± 11 b76 ± 11 b77 ± 11 0.001
Resting heart rate a71 ± 10 a70 ± 9 b69 ± 9 0.001
Hemoglobin (mg/dl) a13.7 ± 1.6 a13.8 ± 1.6 b14.1 ± 1.6 0.002
Creatinine (mg/dl) 0.8 ± 0.3 0.8 ± 0.2 0.8 ± 0.2 0.323
Fasting glucose (mg/dl) a99.1 ± 26.9 b97.5 ± 22.4 b97.9 ± 22.8 0.001
25 (OH) vitamin D3 (ng/mL)
a17.5 ± 6.5 b17.9 ± 6.5 c19.5 ± 7.0 0.001
PTH (pg/ml) a71.3 ± 37.1 b67.5 ± 29.6 c65.2 ± 26.3 0.001
Ferritin (ng/mL) a82.7 ± 104.8 b81.2 ± 110.4 c80.4 ± 123.7 0.001
ALP (U/L) a231.3 ± 75.9 b223.4 ± 76.6 b224.8 ± 69.3 0.001
Triglyceride (mg/dl) a137.3 ± 106.5 b133.4 ± 105.1 b134.0 ± 118.0 0.101
HDL-cholesterol (mg/dl) a51.5 ± 12.5 b52.3 ± 12.7 b52.7 ± 13.0 0.004
ALP alkaline phosphatase, HDL high-density lipoprotein, 25(OH)D 25-dihydroxyvitamin D; PTH = parathyroid hormone
Values were represented as mean ± standard deviation, or n (%)
a, b, cwere designated according to post hoc analysis. Same marker was used to represent no statistically significant difference
Table 2 Body composition and metabolic syndrome components











ASM (kg) 17.1 ± 4.6 17.7 ± 4.7 19.2 ± 4.9 0.001
ASM/weight (%) 18.9 ± 13.7 20.2 ± 13.5 21.7 ± 13.9 0.001
Sarcopenia 509 (14.3) 892 (10.5) 477 (7.3) 0.001
BMI > 25 kg/m2 260 (4.9) 539 (4.5) 441 (4.9) 0.289
BMI < 18.5 kg/m2 301 (5.7) 587 (4.9) 311 (3.5) 0.001
Sarcopenic obesity 157 (4.4) 321 (3.8) 252 (3.9) 0.274
Metabolic syndrome 428 (8.1) 846 (7.1) 645 (7.2) 0.054
aCentral obesity 413 (7.8) 823 (6.9) 564 (6.3) 0.002
High triglyceride 1515 (30.6) 3292 (28.7) 2453 (28.1) 0.006
Low HDL 1667 (33.7) 3558 (31.0) 2324 (26.6) 0.001
Hypertension 2099 (39.5) 4155 (34.6) 3142 (35.0) 0.001
Diabetes mellitus 669 (12.6) 1302 (10.9) 1074 (11.9) 0.002
ASM appendicular skeletal muscle mass, BMI body mass index,
HDL high-density lipoprotein
aWaist circumference of ≥90 cm for male subjects and ≥85 cm for female subjects
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activity groups (Table 4). Figure 1 shows that each CVD
component including stroke, coronary heart disease and
chronic renal failure also had an inverse relationship
with PA level, and Fig. 2 demonstrates a dose-response
relationship between PA level and CVD prevalence and
it is more prominent in female group.
Discussion
The main findings of this study were as follows: 1) the
prevalence rates of HTN, DM, and resting heart rate
were lower in the moderate or high activity group than
in the low activity group; 2) the moderate or high activity
group had more balanced body composition and lower risk
of metabolic syndrome components, including HDL and
TG level; 3) PA was associated with a lower prevalence of
CVD, and this association remained after adjustment for
the potential confounding factors (age, sex, smoking, HTN,
and DM), and body composition parameters and metabolic
syndrome components (muscle mass, BMI, central obesity,
low HDL level, and high triglyceride level).
In 1953, Morris et al. [28] first reported the association
between PA and protection against CVD. Since then,
many other studies have been conducted and have
yielded similar results. The PA guidelines for Americans
that were published in 2008 recommend that 150 min/
week of moderate-intensity aerobic PA or 75 min/week
of vigorous-intensity aerobic PA is associated with pro-
tection from CVD [14]. Although the precise mecha-
nisms of the reduced risk of CVD associated with PA
are not well understood, reductions in the traditional
risk factors, including blood pressure, BMI, glucose ab-
normalities [16, 29], and the chronic anti-inflammatory
effect, mediated by PA were proposed as possible mech-
anisms [13]. However, most prospective cohort studies
that used self-reported data on PA to examine its associ-
ation with CVD risk were published in Western coun-
tries [15], and PA and its association with body
composition or CVD varies with race and lifestyle. In ac-
cordance with previous studies, the prevalence rates of
HTN and DM and fasting glucose level were higher in
the low activity group than in the moderate or high
group. Resting heart rate was lower in the high activity
group than in the low or moderate group. In previous
studies, elevated resting heart rate was associated with
Table 3 Odds ratio of cardiovascular disease (MI, stable angina, stroke, and chronic renal disease) according to physical activity, body
composition, and metabolic syndrome component
Non-adjusted bAdjusted
Odds ratio (95% confidence interval) p value Odds ratio (95% confidence interval) p value
Activity
Low 1
Moderate 0.72 (0.65–0.80) 0.001 0.82 (0.74–0.92) 0.001
High 0.61 (0.55–0.68) 0.001 0.66 (0.59–0.75) 0.001
Sarcopenia 2.17 (1.95–2.43) 0.001 1.63 (1.45–1.84) 0.001
BMI > 25 kg/m2 1.32 (1.10–1.57) 0.003 1.30 (1.08–1.57) 0.005
aCentral obesity 2.40 (2.11–2.72) 0.001 1.82 (1.59–2.08) 0.001
High triglyceride 1.58 (1.45–1.73) 0.001 1.21 (1.10–1.33) 0.001
Low HDL 1.64 (1.50–1.79) 0.001 1.58 (1.44–1.74) 0.001
BMI body mass index, HDL high-density lipoprotein, MI myocardial infarction
aWaist circumference of ≥90 cm for male subjects and ≥85 cm for female subjects
bAdjusted variables: age of >65 years, hypertension, diabetes mellitus, sex, and smoking
Table 4 Association of physical activity level with CVD after adjustment for data sets of potential mediators
Low Moderate p value High p value
Age of >65 years and sex 1.00 0.82 (0.71–0.95) 0.001 0.678 (0.58–0.80) 0.001
Basic modela 1.00 0.82 (0.74-0.92) 0.029 0.66 (0.59–0.75) 0.001
Basic model plus each set of risk factors below
BMI > 25 kg/m2 1.00 0.82 (0.71–0.95) 0.025 0.67 (0.57–0.79) 0.001
Sarcopenia 1.00 0.87 (0.73–1.05) 0.287 0.75 (0.61–0.92) 0.005
Central obesity 1.00 0.83 (0.71–0.96) 0.031 0.68 (0.57–0.80) 0.014
High triglyceride 1.00 0.81 (0.70–0.95) 0.029 0.70 (0.59–0.83) 0.001
Low HDL 1.00 0.81 (0.70–0.95) 0.029 0.71 (0.60–0.84) 0.001
BMI body mass index, CVD cardiovascular disease
aAge, sex, smoking, hypertension, and diabetes mellitus
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metabolic syndrome and poor outcome in patients with
heart failure or coronary heart disease [30, 31]. It is in-
teresting that the levels of biomarkers such as vitamin
D, serum ferritin, ALP, and PTH differed according to
PA level, as shown in Table 1. Vitamin D deficiency and
elevated levels of ALP, ferritin, and PTH were identified
as predictors of metabolic syndrome or poor prognosis
of CVD in previous studies [32–35]. Thus, the favorable
effect of PA on the prevalence of CVD might have rele-
vance to these biomarkers, and further prospective
studies are needed.
The moderate or high activity group had significantly
lower prevalence rates of sarcopenia, underweight, and
abdominal obesity, whereas no significant difference was
observed in general obesity defined as a BMI of ≥25 kg/m2.
From these findings, we can infer that regular PA does not
simply reduce weight but should be coupled with more
balanced body composition and physical fitness, as sarco-
penia, central obesity, and underweight were reported as
independent risk factors of developing CVD and mor-
tality or poor prognosis in patients with CVD and
general obesity [36–41]. Analysis of the association
between PA and CVD revealed a positive dose-response
relationship, with an OR of 0.822 (95% CI, 0.737–0.916)
for the moderate group and 0.663 (0.589–0.748) for the
high group. In IPAQ scale, strength trainings such as
digging, heavy lifting or fast bicycling are included in
moderate to high intensity activities. These activities
strengthen and maintain lean muscle mass as well as
burning calories. Previous studies reported that muscle
mass is associated with cardiovascular risk, prevalence of
cardiovascular disease and insulin resistance [42–45].
Thus, in line with previous studies, the results of this
study also showed strength trainings assessed by IPAQ
scale is associated with physical fitness and lower
prevalence of CVD. These risk reduction remained
significant even after adjusting for conventional risk
factors of CVD, including age, HTN, DM, sex, and
Fig. 1 Prevalence of cardiovascular disease according to physical activity
Fig. 2 Relative risk of CVD according to physical activity
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smoking. A dose-response relationship was difficult to
define because of the different questionnaires used
across various studies to assess PA in 1 or more do-
mains of activity (leisure-time, household, occupation,
and commuting activity), with most of the studies
assessing primarily leisure-time PA [15]. In our study,
we used the IPAQ as mentioned earlier, and the classifi-
cation of PA was similar with the definition in the 2008
American guidelines [14], which defined “moderate” as at
least 150 min/week of moderate-intensity activity or
75 min/week of vigorous activity and “high” as 300 min/
week of moderate-intensity activity or 150 min/week of
vigorous activity. Previous studies that were based on as-
sessments according to the 2008 guidelines reported that
the moderate- and high-intensity groups had 20–25% and
30–35% reduction in the risk of CVD [12, 13, 46]. These
results approximately equal our data, as the risk reduction
rates were 28 and 34% in the moderate and high groups,
respectively. Furthermore, the OR was more significant in
the female subjects than in the male subjects, as shown in
Fig. 2, concurring with the results of previous studies that
reported a median risk reduction of 40% in female
subjects and 30% in male subjects [47–50]. Thus, the
dose-response relationship and prominent effect of PA in
female subjects were observed in the Asian population.
Considering of these clear relationship with IPAQ scale
and physical fitness and clinical outcome, IPAQ could be
used as a reliable questionnaire to assess physical activity
in patients with high risk of CVD event including patients
with diabetes, obesity and metabolic syndrome.
To further understand the association between PA
level and CVD, an additional logistic analysis was con-
ducted after combining PA with the conventional risk
factors and body composition parameters (Table 4).
After adjusting for these factors, the relationship in the
moderate or high activity group remained significant.
Whether higher PA level mitigate the risk of CVD asso-
ciated with being overweight or obese is controversial
[51–53]. Our results show that PA level has a strong
association with the prevalence of CVD, independent of
body composition, including both general and central
obesities and other conventional risk factors of CVD.
Some limitations should be considered in the interpret-
ation of this study. First, it used a cross-sectional design,
which limited the ability to detect causal relationships.
Therefore, the cause-and-effect relationships of PA level
with cardiometabolic risk factors and prevalence of CVD
cannot be precisely inferred, although this study included
a representative sample of the general Korean population.
Second, this study was based on data obtained by using
the IPAQ-short form for PA level. Thus, we could not
fully exclude the effects of information bias. Third,
although all participants were initially evaluated the
heath interview and heath examination at the mobile
examination center (bus) which means at least they
were able to ambulate, it is impossible to fully exclude
the possibility of reverse causation of the association
between PA and CVD. It means that our results con-
fined the relationship between the PA and prevalence
of CVD not causal relationship of them. Thus, further
randomized controlled trials regarding the incidence of
CVD according to PA are necessary.
Conclusions
In conclusion, moderate or high PA level was associated
with a low prevalence of CVD (stroke, myocardial infarc-
tion, stable angina, and chronic renal disease), which was
independent of body composition (general or central
obesity, and sarcopenia) and conventional risk factors in
the Korean population. Furthermore, the dose-response
relationship between PA level and the prevalence of CVD,
and the more-prominent effect in female subjects were in
line with those in previous studies conducted in the
Western population.
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